Digest

Samsung Ventures and existing investor Merck Global Health Innovation Fund led the funding round WellDoc, whose BlueStar technology is focused on adults with Type 2 diabetes, has drawn $22 million in a Series B round of funding from Samsung Ventures and existing investor Merck Global Health...

Communication today is faster and more ephemeral than ever. We fire off emails, skip the punctuation in our texts, and watch our photos and messages vanish in seconds on Snapchat. Digital tools have made communicating with others easier but not necessarily more thoughtful, and this bothered...

The next time you stop by your local supermarket, take a long, hard look at the yellow bananas in the produce section. That’s because bananas might be extinct within just a few years, say Dutch researchers, and that could open the door for synthetic biologists...